 Hip fracture is an increasing problem. Anemia is a common finding in these patients with a prevalence ranging from 24 to 44 and is a strong negative prognostic marker. Several studies have explored whether interventions to improve anemia result in better outcomes. Thus, alternatives to allogenic red cell transfusion have been suggested in hip fracture, such as IV iron and tranexamic acid. 